Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.
about
Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma.Maintenance therapy with immunomodulatory drugs after autologous stem cell transplantation in patients with multiple myeloma: a meta-analysis of randomized controlled trials.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maHigh-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Thalidomide in multiple myeloma: past, present and future.Current status of new drugs for the treatment of patients with multiple myeloma.A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial.Maintenance therapy in multiple myeloma.Autologous stem cell transplantation in the elderly including pre- and post-treatment options.High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.Targeted treatments to improve stem cell outcome: old and new drugs.New therapies in multiple myeloma.The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myeloma.Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement.Guidelines for the diagnosis and management of multiple myeloma 2011.Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice.Evolving therapeutic paradigms for multiple myeloma: back to the future.Stem cell transplantation for multiple myelomaLow tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients.Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma.Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.
P2860
Q34034447-299703E6-3007-49EA-A485-5CC06178EE26Q34973992-578E1BDC-A7DD-4437-8328-7D1FA59FA399Q35605318-44EDA246-DF53-4325-ACA4-E33586CDE30EQ36407446-330A2ADE-E19D-4628-B248-FE091EA0D6AFQ36616493-B1ACA544-556A-432D-988C-E019F25A160CQ36649839-15C33244-B5A0-4760-A115-FB1AC98C14F8Q36654092-25A9E7BE-6AF5-4EAF-AF94-1F7EAF5381B8Q36754178-FD2F6B5B-3C76-425F-8845-BBB1DF515AFEQ36902832-B165CEDC-A0F7-47A5-B7D5-68D8E99E0E4CQ36902837-80098C76-4054-4076-A687-641496F37A70Q36927960-B88CDCC0-C12B-4A48-8C00-85A8FD13CE55Q36986576-74DEB984-D5F0-4457-A2DD-5E5876EA0589Q37209935-ED34E648-6228-44EE-B2C1-680FB52B4D27Q37373269-CC5EF97F-624E-4216-BEF6-6769DFF93EEBQ37761370-FA0EB400-DF14-4287-80CD-A7CEE710A7F9Q37835695-4C468351-BF16-4523-8B89-46CBFAFEC7C3Q37875193-DAECD89F-DE74-4A44-A120-5FFE0285DACDQ37991783-CB57C875-C0DA-4E75-8382-A50A571C0B82Q38033590-231F9952-CD2A-49F9-ACEE-285B1F9ABB18Q41819684-A4CE10F8-D4C4-4D4A-8A81-55EA584F5BE5Q45064253-55A02356-EA43-4199-A60A-EE508612CD88Q46772655-B2775E44-BF67-474C-8ABA-77816E96021FQ47599429-48423C9E-9E64-4B7A-BCD4-8E471EFE1B75
P2860
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Results of a multicenter rando ...... tologous stem cell transplant.
@en
Results of a multicenter rando ...... tologous stem cell transplant.
@nl
type
label
Results of a multicenter rando ...... tologous stem cell transplant.
@en
Results of a multicenter rando ...... tologous stem cell transplant.
@nl
prefLabel
Results of a multicenter rando ...... tologous stem cell transplant.
@en
Results of a multicenter rando ...... tologous stem cell transplant.
@nl
P2093
P1476
Results of a multicenter rando ...... tologous stem cell transplant.
@en
P2093
A Keith Stewart
Andrew R Belch
Anna Sadura
Chaim Shustik
Christine I Chen
Darrell White
Kang Howson-Jan
Keyue Ding
Lois Shepherd
P304
P356
10.1158/1078-0432.CCR-04-1106
P407
P577
2004-12-01T00:00:00Z